DHX9 promotes migration of lung adenocarcinoma cells [83], whereas DHX36 knockdown increases migration and proliferation and reduces chemotherapeutic responses in non-small-cell lung carcinoma (NSCLC) [84]. Here, DHX9 is linked to non-small cell lung carcinoma.